Health Policy Snapshot: September 2023

Health Policy Snapshot: September 2023

Feds Release Top 10 Medicare Part D Drugs List; More Lawsuits Filed Against Inflation Reduction Act (IRA) The Centers for Medicare & Medicaid Services (CMS) released its long-awaited list of the first 10 Medicare Part D drugs that will be subject to negotiation...
Health Policy Snapshot: September 2023

Health Policy Snapshot: August 2023

More lawsuits filed against the Inflation Reduction Act, while Congressional Democrats push additional reformsJoining PhRMA, the U.S. Chamber of Commerce, Merck and Bristol Myers Squibb, pharma companies JanssenJ&J and Astellas filed July lawsuits against...
Health Policy Snapshot: September 2023

Health Policy Snapshot: February 2023

CMS Issues Guidance on How to Handle Prescription Drug Prices that Increase Higher than Inflation The 2022 Inflation Reduction Act (IRA), touted several times by President Biden in last week’s “State of the Union” address, requires prescription drug companies to pay...
What We’re Watching in Health Care in 2022

What We’re Watching in Health Care in 2022

We continue to navigate after two years of a pandemic and economic tumult with long-term systemic impacts. As we assessed 2021 and looked to 2022, CLA released our Top 10 list of insights across all industries. Building on this, we decided to look at 2022 through...